Adicet Bio Appoints Michael Grissinger to the Board of Directors
–Mr. Grissinger brings more than four decades of leadership experience in pharmaceutical business development and strategic transactions– Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage...